Bibliography
- Lotvall J, Pullertis T. Treating asthma with Anti-IgE or Anti IL-5. Curr Pharm Des 1999;5:757-70
- Kolbeck R, Kozhich A, Koike M, Medi-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell mediated cytotoxicity function. J Allergy Clin Immunol 2010;125(1):1344-53
- Kotsimbos ATC, Hamid Q. IL5 and IL-5 receptor in Asthma. Mem Inst Oswaldo Cruz 1997;92(Suppl II):75-91
- Busse W, Ring J, Huss-Marp J, Kahn JE. A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma. J Allergy Clin Immunol 2010;125(4):803-13
- Hadar P, Brightling CE, Hargadon B, Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84
- Nair P, Pizzichini MMM, Kjarsgaard M, Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-93
- Stein ML, Villanueva JM, Buckmeier BK, Anti IL-5 (mepolizumab) therapy reduces eosinophil activations ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol 2008;121(6):1473-83
- Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as Anti-Interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204
- Migita M, Yamaguchi N, Mita S, Characterization of the human IL-5 receptors on eosinophils. Cell Immunol 1991;133:484-97
- Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007;119:1303-10
- Tavernier J, Devos R, Cornelis S, A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 1991;66:1175-84
- Zaks-Zilberman M, Harrington AE, Ishino T, Chaiken IM. Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging. J Biol Chem 2008;283:13398-406
- Ogata N, Kouro T, Yamada A, JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and beta c subunit, respectively, and are activated upon IL-5 stimulation. Blood 1998;91:2264-71
- Takaki S, Kanazawa H, Shiiba M, Takatsu K. A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol 1994;14:7404-13
- Koike M, Nakamura K, Furuya A, Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity. Hum Antibodies 2009;18:17-27
- Busse WW, Katial R, Gossage D, Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol 2010;125:1237-44
- Gossage D, Geba G, Gillen A, A multiple ascending subcutaneous dose study of MEDI-563, A humanized anti-IL-5RA monoclonal antibody, in adult asthmatics (clinicaltrails.gov Identifier: NCT00783289). Annual Congress of the European Respiratory Society (ERS);2010